A multidisciplinary perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer. - Dent, S.; Ammendolea, C.; Christofides, A.; Edwards, S.; Incekol, D.; Pourmirza, B.; Kfoury, S.; Poirier, B. (Current Oncology, 2019)